Concentrations of H1-Receptor Antagonist in the Human Nasal Mucosa

Table 1

Characters of the participants and results of the concentration of BB in the serum and nasal mucosa.

				Sampling time after	Concentration	Concentration
	Case	Age (years)	Sex	oral administration	in the serum	in the nasal mucosa	Antigen
				of BB (h:m)	(ng/mL)	(ng/g)
Group I	1	53	Male	1:10	155.98	111.05	Amb, Asp, Candida, Cha, Cry, Dp, HD
	2	25	Female	1:30	132.34	108.3	Cha, Cry, Dp, HD
	3	29	Male	1:35	67.98	47.79	Cha, Cry, Dp, HD
	4	68	Male	1:40	98.14	76	Dp, HD
	5	68	Male	1:40	74.62	79.57	Candida, Dp, HD
	6	31	Male	1:45	49.35	97.3	Cha, Cry, Dp, HD
	7	60	Male	1:50	86.85	99.2	Candida, Cha, Cry, Dp, HD
	8	55	Male	2:00	109.27	108.6	HD
	9	17	Female	2:00	83.5	98	Amb, Asp, Candida, Dp, HD
	10	13	Male	2:10	119.41	186.1	Cry, Dp
Group II	11	38	Female	0:55	96.22	183.67	non
	12	57	Male	1:00	71.38	66.7	non
	13	55	Female	1:20	137.21	138.2	non
	14	52	Male	1:20	121.58	141.5	non
	15	46	Male	1:30	65.04	163.88	non
	16	64	Female	1:30	107.48	187.01	non
	17	52	Female	1:40	197.55	123.85	non
	18	50	Male	1:40	85.14	57.86	non
	19	76	Male	2:00	141.6	150.57	non
	20	56	Male	2:00	95.47	108.7	non

Amb: Ambrosia elatior; Asp: Aspergillus; BB: Bepotastine Besilate; Cha: Chamaecyparis obtuse; Cry: Cryptomeria japonica; Dp: Dermatophagoides pteronyssinus; HD: Housedust.